VanEck Associates’s Cognyte Software CGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,002
Closed -$69K 1428
2022
Q3
$69K Buy
17,002
+57
+0.3% +$270 ﹤0.01% 1230
2022
Q2
$72K Buy
16,945
+258
+2% +$1.81K ﹤0.01% 1264
2022
Q1
$189K Buy
16,687
+93
+0.6% +$1.07K ﹤0.01% 1111
2021
Q4
$260K Sell
16,594
-5,978
-26% -$121K ﹤0.01% 1052
2021
Q3
$464K Sell
22,572
-1,814
-7% -$46.4K ﹤0.01% 927
2021
Q2
$597K Buy
24,386
+4,926
+25% +$122K ﹤0.01% 884
2021
Q1
$541K Buy
+19,460
New +$578K ﹤0.01% 843

Other funds holding CGNT

VanEck Associates's CGNT Position: Q4 2022 in Review

VanEck Associates sold out of Cognyte Software (CGNT) in Q4 2022, closing a stake of 17,002 shares — an estimated $69K sold.

VanEck Associates first reported a position in CGNT in Q1 2021 and held it in 7 quarters. The position peaked at $597K in Q2 2021. 100 funds tracked by Wall St. Rank hold CGNT as of Q4 2022.

  • VanEck Associates reported no remaining Cognyte Software position as of Q4 2022 after selling out during the quarter.
  • VanEck Associates sold 17,002 Cognyte Software shares in Q4 2022, an estimated $69K.
  • VanEck Associates first reported a position in Cognyte Software in Q1 2021 and held it in 7 quarters.
  • VanEck Associates's Cognyte Software position peaked at $597K in Q2 2021.
  • 100 funds tracked by Wall St. Rank held Cognyte Software as of Q4 2022.

Based on VanEck Associates's 13F filing for Q4 2022, filed 8 Feb 2023.